{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:52:36Z","timestamp":1775296356952,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1124\/dmd.104.001057","type":"journal-article","created":{"date-parts":[[2004,9,9]],"date-time":"2004-09-09T00:24:52Z","timestamp":1094689492000},"page":"1392-1401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS"],"prefix":"10.1016","volume":"32","author":[{"given":"Eileen","family":"Brantley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Alley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis D.","family":"Hose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey D.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm F.G.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Sausville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherman F.","family":"Stinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.104.001057_bib1","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1021\/jm9700326","article-title":"Design and synthesis of potent antitumor 5,4\u2032-diaminoflavone derivatives based on metabolic considerations.","volume":"40","author":"Akama","year":"1997","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.104.001057_bib2","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.","volume":"48","author":"Alley","year":"1988","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.104.001057_bib3","first-page":"813","article-title":"Pharmacologic evaluations of fluorinated 2-(4-amino phenyl) benzothiazole analogs with unique anti-cancer activities.","volume":"41","author":"Alley","year":"2000","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1124\/dmd.104.001057_bib4","first-page":"239","article-title":"Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles.","volume":"1","author":"Bradshaw","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/dmd.104.001057_bib5","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.bjc.6600225","article-title":"In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles.","volume":"86","author":"Bradshaw","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1124\/dmd.104.001057_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/bjc.1998.510","article-title":"Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo.","volume":"78","author":"Bradshaw","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1124\/dmd.104.001057_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/0929867013373714","article-title":"The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds.","volume":"8","author":"Bradshaw","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1124\/dmd.104.001057_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/bjc.1998.122","article-title":"2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.","volume":"77","author":"Bradshaw","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1124\/dmd.104.001057_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1081\/DMR-120026497","article-title":"Chemical-induced apoptosis: formation of the Apaf-1 apoptosome.","volume":"35","author":"Cain","year":"2003","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.104.001057_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nbt0598-444","article-title":"An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy.","volume":"16","author":"Chase","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1124\/dmd.104.001057_bib11","first-page":"5196","article-title":"Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.","volume":"60","author":"Chua","year":"2000","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.104.001057_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/jm981076x","article-title":"Antitumor benzothiazoles. 7. Synthesis of 2-(4-acylaminophenyl-)benzothiazoles and investigations into the role of acetylation in the antitumor activities of the parent amines.","volume":"42","author":"Chua","year":"1999","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.104.001057_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1006\/taap.1998.9999","article-title":"Carbaryl, a carbamate insecticide, is a ligand for the hepatic Ah (dioxin) receptor.","volume":"152","author":"Denison","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.104.001057_bib14","first-page":"767","article-title":"The anti-malarial artesunate is also active against cancer.","volume":"18","author":"Efferth","year":"2001","journal-title":"Int J Oncol"},{"key":"10.1124\/dmd.104.001057_bib15","series-title":"Cancer Drug Discovery and Development: Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials and Approval","first-page":"153","article-title":"NCI specialized procedures in preclinical drug evaluations","author":"Hollingshead","year":"2004"},{"key":"10.1124\/dmd.104.001057_bib16","first-page":"1265","article-title":"Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: a potential surrogate marker for patient sensitivity.","volume":"2","author":"Hose","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/dmd.104.001057_bib17","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/jm001104n","article-title":"Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles.","volume":"44","author":"Hutchinson","year":"2001","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.104.001057_bib18","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/jm011025r","article-title":"Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs.","volume":"45","author":"Hutchinson","year":"2002","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.104.001057_bib19","doi-asserted-by":"crossref","first-page":"31518","DOI":"10.1016\/S0021-9258(18)31725-3","article-title":"Potent transactivation domains of the Ah receptor and the Ah receptor nuclear translocator map to their carboxyl termini.","volume":"269","author":"Jain","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.104.001057_bib20","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1128\/MCB.15.12.7010","article-title":"The human growth hormone gene is regulated by a multicomponent locus control region.","volume":"15","author":"Jones","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.104.001057_bib21","first-page":"4391","article-title":"Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy.","volume":"58","author":"Jounaidi","year":"1998","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.104.001057_bib22","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1021\/jm990104o","article-title":"Antitumor benzothiazoles. 8. Synthesis, metabolic formation and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles.","volume":"42","author":"Kashiyama","year":"1999","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.104.001057_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/mol.62.1.143","article-title":"Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1\/1A2.","volume":"62","author":"Kuffel","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.104.001057_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/004982598239362","article-title":"Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines.","volume":"28","author":"Lampen","year":"1998","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.104.001057_bib25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.bjc.6600719","article-title":"Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo.","volume":"88","author":"Leong","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1124\/dmd.104.001057_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/mol.61.1.13","article-title":"Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole.","volume":"61","author":"Loaiza-Perez","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.104.001057_bib27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1124\/mol.63.3.766","article-title":"Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole.","volume":"63","author":"Monks","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.104.001057_bib28","first-page":"533","article-title":"The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets.","volume":"12","author":"Monks","year":"1997","journal-title":"Anticancer Drug Des"},{"key":"10.1124\/dmd.104.001057_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1039\/b209067h","article-title":"Antitumor benzothiazoles. Frontier molecular orbital analysis predicts bioactivation of 2-(4-aminophenyl)benzothiazoles to reactive intermediates by cytochrome P4501A1.","volume":"1","author":"O\u2019Brien","year":"2003","journal-title":"Org Biomol Chem"},{"key":"10.1124\/dmd.104.001057_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/dmd.32.1.80","article-title":"The Olivacine derivative S 16020 (9-hydroxy-5,6-dimethyl-N-[2-(dimethylamino)ethyl)-6H-pyrido(4,3-B)-carbazole-1-carboxamide) induces CYP1A and its own metabolism in human hepatocytes in primary culture.","volume":"32","author":"Pichard-Garcia","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.104.001057_bib31","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0006-2952(99)00046-5","article-title":"Selective toxicity of the tricyclic thiophene NSC 652287 in renal carcinoma cell lines: differential accumulation and metabolism.","volume":"57","author":"Rivera","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.104.001057_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0022-3565(24)38762-2","article-title":"Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?","volume":"296","author":"Rochat","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.104.001057_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-642-79451-3_8","article-title":"Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression.","volume":"17","author":"Safe","year":"1995","journal-title":"Arch Toxicol Suppl"},{"key":"10.1124\/dmd.104.001057_bib34","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1021\/jm9600959","article-title":"Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.","volume":"39","author":"Shi","year":"1996","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.104.001057_bib35","series-title":"Anticancer Drugs: Reactive Metabolism and Interactions","first-page":"79","article-title":"Metabolism and pharmacokinetic behavior of cyclophosphamide and related oxazaphosphorines","author":"Sladek","year":"1994"},{"key":"10.1124\/dmd.104.001057_bib36","first-page":"1035","article-title":"Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.","volume":"12","author":"Stinson","year":"1992","journal-title":"Anticancer Res"},{"key":"10.1124\/dmd.104.001057_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.bjc.6600722","article-title":"DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells.","volume":"88","author":"Trapani","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1124\/dmd.104.001057_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0960-894X(00)00027-5","article-title":"Antitumour benzothiazoles. Part 10: the synthesis and antitumour activity of benzothiazole substituted quinol derivatives.","volume":"10","author":"Wells","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.104.001057_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.pharmtox.39.1.103","article-title":"Induction of cytochrome P4501A1.","volume":"39","author":"Whitlock","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624030472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624030472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.104.001057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:02:25Z","timestamp":1739898145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624030472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0090955624030472"],"URL":"https:\/\/doi.org\/10.1124\/dmd.104.001057","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.104.001057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}